Glutathione S-transferase-pi expression in prechemotherapy and postchemotherapy tumor samples from patients with locally advanced breast carcinomas

Breast Journal

Volumn 2, Issue 4, 1996, Pages 246-252

  Shin, Hyung Ju C ^a   Sneige, Nour ^a,b   Sahin, Aysegul ^a   Ibrahim, Nuhad K ^a   Neely Atkinson, E ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Glutathione S transferase pi expression; Locally advanced breast carcinoma

Indexed keywords

EID: 28844439847     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4741.1996.tb00105.x     Document Type: Article

References (22)

1. Booser DJ, Hortobagyi GN. Treatment of locally advanced breast cancer. Semin Oncol 1992;19:278-85.
2. Hortobagyi GN. Comprehensive management of locally advanced breast cancer. Cancer 1990;66(suppl):1387-91.
3. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62: 2507-16.
4. Valagussa P, Zambetti M, Bonadonna G, Zucali R, Mezzanotte G, Veronesi U. Prognostic factors in locally advanced breast cancer: long-term results following primary chemotherapy. Breast Cancer Res Treat 1990;15:137-47.
5. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82: 1539-45.
6. Mauriac L, Durand M, Avril A, Dilhuydy J.-M. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Ann Oncol 1991;2:347-54.
7. Jacquillat C, Weil M, Baillet F, et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990;66:119-29.
8. Abu-Farsakh H, Sneige N, Atkinson N, Hortobagyi G. Tumor nuclear grade as a predictor of tumor response to preoperative chemotherapy in patients with locally advanced breast cancers. Mod Pathol 1994;7:12A (abstract).
9. O'Reilly SM, Camplejohn RS, Rubens RD, Richards MA. DNA flow cytometry and response to preoperative che motherapy for primary breast cancer. Eur J Cancer 1992;28: 681-83.
10. Remvikos Y, Jouve M, Beuzeboc P, Viehl P, Magdelenat H, Pouillart P. Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates. Eur J Cancer 1993;29A:1843-48.
11. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-82.
12. Wolf CR, Waring CJ, Black SM, Hayes JD. Glutathione S-transferase in resistance to chemotherapeutic agents. In: Hayes JD, Pickett CB, Mantle TJ, eds. Glutathione S-transferase and drug resistance. London: Taylor and Francis, 1990; 295-307.
13. Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE, Cowan KH. Overexpression of a novel anionic glutathione transferase in multidrug resistant human breast cancer cells. J Biol Chem 1986;261:15544-49.
14. Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance. Cancer Res 1992;52:1416-21.
15. Di Ilio C, Sacchatta P, Del Boccio G, La Rovere G, Federici G. Glutathione peroxidase, glutathione S-transferase and glutathione reductase activities in normal and neoplastic human breast tissue. Cancer Lett 1985;29:37-42.
16. Shea TC, Claflin G, Comstock KE, et al. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Cancer Res 1990;50:6848-53.
17. Moscow JA, Fairchild CR, Madden MJ, et al. Expression of anionic glutathione S-transferase and p-glycoprotein genes in human tissues and tumors. Cancer Res 1989;49:1422-28.
18. Moscow JA, Townsend AJ, Goldsmith ME, et al. Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci USA 1988;85: 6518-22.
19. Gilbert L, Elwood LJ, Merino M, et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 1993;11:49-58.
20. Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowan KH. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 1990;137:845-53.
21. Cairns J, Wright C, Cattan AR, et al. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 1992;166:19-25.
22. Molina R, Oesterreich S, Zhou J-L, et al. Glutathione S-transferase-pi in breast tumors evaluated by three techniques. Dis Markers 1993;11:71-82.